Literature DB >> 2780793

Apomorphine stimulation of male copulatory behavior is prevented by the oxytocin antagonist d(CH2)5 Tyr(Me)-Orn8-vasotocin in rats.

A Argiolas1, M Collu, P D'Aquila, G L Gessa, M R Melis, G Serra.   

Abstract

The effect of the intracerebroventricular (ICV) injection of the oxytocin antagonist d(CH2)5Tyr(Me)-Orn8-vasotocin on the stimulation of copulatory behavior induced by the dopamine (DA) agonist apomorphine was studied in male rats. Apomorphine (80 micrograms/kg SC) given 5 min before mating tests decreased intromission frequency and ejaculation latency in experienced male rats. Such effects were abolished and reversed by pretreatment with 50 and 1000 ng of the oxytocin antagonist given ICV 5 min before apomorphine. The peptide per se markedly increased intromission and ejaculation latency and abolished ejaculation in control rats. The results suggest that brain oxytocin is implicated in the expression of sexual behavior, and apomorphine might improve male copulatory behavior by releasing oxytocin in brain.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2780793     DOI: 10.1016/0091-3057(89)90433-4

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  11 in total

Review 1.  The neurobiology of social attachment: A comparative approach to behavioral, neuroanatomical, and neurochemical studies.

Authors:  Kimberly A Young; Yan Liu; Zuoxin Wang
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2008-03-02       Impact factor: 3.228

Review 2.  The Female Sexual Response: Current Models, Neurobiological Underpinnings and Agents Currently Approved or Under Investigation for the Treatment of Hypoactive Sexual Desire Disorder.

Authors:  Sheryl A Kingsberg; Anita H Clayton; James G Pfaus
Journal:  CNS Drugs       Date:  2015-11       Impact factor: 5.749

3.  An evaluation of central penetration from a peripherally administered oxytocin receptor selective antagonist in nonhuman primates.

Authors:  Aaron L Smith; Hasse Walum; Fawn Connor-Stroud; Sara M Freeman; Kiyoshi Inoue; Lisa A Parr; Mark M Goodman; Larry J Young
Journal:  Bioorg Med Chem       Date:  2016-10-31       Impact factor: 3.641

Review 4.  Normal male sexual function: emphasis on orgasm and ejaculation.

Authors:  Amjad Alwaal; Benjamin N Breyer; Tom F Lue
Journal:  Fertil Steril       Date:  2015-09-16       Impact factor: 7.329

5.  Brain oxytocin receptors mediate ejaculation elicited by 7-hydroxy-2-(di-N-propylamino) tetralin (7-OH-DPAT) in anaesthetized rats.

Authors:  P Clément; M Peeters; J Bernabé; P Denys; L Alexandre; F Giuliano
Journal:  Br J Pharmacol       Date:  2008-05-12       Impact factor: 8.739

Review 6.  The hormonal control of ejaculation.

Authors:  Giovanni Corona; Emmanuele A Jannini; Linda Vignozzi; Giulia Rastrelli; Mario Maggi
Journal:  Nat Rev Urol       Date:  2012-08-07       Impact factor: 14.432

Review 7.  Oxytocin and Major Depressive Disorder: Experimental and Clinical Evidence for Links to Aetiology and Possible Treatment.

Authors:  David A Slattery; Inga D Neumann
Journal:  Pharmaceuticals (Basel)       Date:  2010-03-16

Review 8.  An Update of the International Society of Sexual Medicine's Guidelines for the Diagnosis and Treatment of Premature Ejaculation (PE).

Authors:  Stanley E Althof; Chris G McMahon; Marcel D Waldinger; Ege Can Serefoglu; Alan W Shindel; P Ganesan Adaikan; Edgardo Becher; John Dean; Francois Giuliano; Wayne Jg Hellstrom; Annamaria Giraldi; Sidney Glina; Luca Incrocci; Emmanuele Jannini; Marita McCabe; Sharon Parish; David Rowland; R Taylor Segraves; Ira Sharlip; Luiz Otavio Torres
Journal:  Sex Med       Date:  2014-06       Impact factor: 2.491

Review 9.  Advances in treating premature ejaculation.

Authors:  Selahittin Cayan; Ege Can Serefoğlu
Journal:  F1000Prime Rep       Date:  2014-07-08

Review 10.  Emerging and investigational drugs for premature ejaculation.

Authors:  Chris G McMahon
Journal:  Transl Androl Urol       Date:  2016-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.